Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story ...

One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.

BOCA RATON, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) will release its fourth quarter and full year 2025 financial results before the market opens on Monday, March 2, 2026.

How customers rated ADT ADT is an established home security company that offers a range of security solutions for residential and small business properties. Based on reviews from ConsumerAffairs, it ...

The REVELUTION (Relugolix versus Leuprolide Cardiac) trial compared coronary plaque after 2 types of androgen deprivation therapy (ADT) for prostate cancer.

BOCA RATON, Fla., Feb. 09, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) today announced its inclusion into the S&P SmallCap 600® Index, effective prior to the opening of trading this morning, Feb. 9, ...

ADT’s entrance in the S&P SmallCap 600 Index took effect on Feb. 9, 2026, marking a significant achievement for the company. Chairman, President and CEO Jim DeVries highlighted that this recognition ...

She went from the corporate life to running her own firm.

As India looks to grab a position at the high table of global tech innovations, its farmlands have been a testimony to an intelligent revolution taking place that cements its technology prowess.

The Marines also see what is called Future Attack Strike as addressing demands that will arise when the F/A-18C/D Hornet is ...